E2B: Energy to Business: Competitive Edge: Why AI Enhances ETRM Systems

 

Today’s edge computing technologies assist all industries and markets, but can AI and machine learning transform energy trading and risk management? That was the question posed to three industry experts: Kent Landrum, Managing Director of Process & Technology at Opportune, Mark Swann, Director of the Process & Technology Group at Opportune, and Vincent Annunziata, Co-founder of Venus Technology Ventures.

They brought along their A-game with a whole bag of insights on the latest AI and edge computing trends for the energy market.

Recent headlining news announced that Baker Hughes, Shell, Microsoft and C3.ai partnered to form an open AI energy initiative. This initiative aims to solve operational efficiency challenges, including energy management, predictive maintenance, well development optimization, and more by utilizing AI as the core technology driver. Is this a game-changer for the industry?

“I think the partnership is a reflection of the momentum that AI is gaining in the industry,” Landrum said. “It signals that this is an area where companies are willing to invest in improving returns in a market that’s otherwise a pretty challenging business climate. When I look through that list of partners, I see big, established, trusted technology players, I see an innovator, and I see energy-industry stalwarts that have the wherewithal to make this kind of program go.”

In terms of energy traders and AI addressing their needs, Swann said the most important thing was data accessibility and speed.

“It could be public market data, it could be private positional data, or it could be results from models and things that I’m running locally on my network,” Swann said.

If the market could enhance the capability to access all the data a trader is looking for in one area, that could be a huge benefit.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Agentic AI
Agentic AI: IBM is Powering the Next Wave of Autonomous, Intelligent Decision-Making
March 14, 2025

Retail has long embraced automation, but now it’s taking a leap into a new frontier—autonomous decision-making. Enter agentic AI, a technology that doesn’t just automate tasks but makes real-time, intelligent decisions. With major retailers like Walmart integrating AI-driven fulfillment robots and brands such as Bath & Body Works rolling out personalized AI-powered shopping assistants,…

Read More
QSR connectivity
How IBM and Hughes Are Powering the Future of QSR Connectivity & Fast Food Tech
March 14, 2025

Quick service restaurants (QSRs) are under increasing pressure to enhance speed, efficiency, and customer experience—all while managing a growing network of digital systems. From AI-powered ordering kiosks to real-time kitchen automation, modern QSRs are more connected than ever. The restaurant AI market was valued at $9.68 billion in 2024, and expected to reach $49 billion…

Read More
Trade tariffs
From Asia to the World: How Dimerco is Helping Businesses Navigate New Trade Tariffs and Supply Chain Shifts
March 13, 2025

The global supply chain is once again at a crossroads, with shifting trade policies, geopolitical tensions, and economic fluctuations shaping the way goods move across the world. The looming threat of new trade tariffs on imports from Asia, combined with fluctuating shipping rates, is creating a challenging landscape for logistics professionals. With businesses re-evaluating…

Read More
sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More